FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for holidays. We...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
The new online Learning Center with new content can still be found under the “Training” folder on ...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...